Oseltamivir for treatment and prophylaxis of influenza infection
about
sameAs
The value of neuraminidase inhibitors for the prevention and treatment of seasonal influenza: a systematic review of systematic reviewsSystematic review of influenza resistance to the neuraminidase inhibitorsNeuraminidase inhibitors for the treatment of influenza infection in people with cystic fibrosisNeuraminidase inhibitors for the treatment of influenza infection in people with cystic fibrosisNeuraminidase inhibitors for the treatment of influenza infection in people with cystic fibrosisNeuraminidase inhibitors for the treatment of influenza infection in people with cystic fibrosisInfluenza treatment and prophylaxis with neuraminidase inhibitors: a reviewViral replication rate regulates clinical outcome and CD8 T cell responses during highly pathogenic H5N1 influenza virus infection in micePeramivir for the treatment of influenza.Are clozapine patients at risk for blood dyscrasias with concomitant tamiflu use?Detection of E119V and E119I mutations in influenza A (H3N2) viruses isolated from an immunocompromised patient: challenges in diagnosis of oseltamivir resistance.Assessing the in vitro fitness of an oseltamivir-resistant seasonal A/H1N1 influenza strain using a mathematical modelAdverse drug reaction profile of oseltamivir in Indian population: A prospective observational studyGeneration of Adaptive Immune Responses Following Influenza Virus Challenge is Not Compromised by Pre-Treatment with the TLR-2 Agonist Pam2CysThe I222V neuraminidase mutation has a compensatory role in replication of an oseltamivir-resistant influenza virus A/H3N2 E119V mutantFinding a new drug and vaccine for emerging swine flu: what is the concept?Design of multiligand inhibitors for the swine flu H1N1 neuraminidase binding site.Satisfying the need for rapid diagnosis of new variant influenza A H1N1.
P2860
Q21090775-7D300E85-7DCF-47F4-9B07-884427582EE3Q21261835-850DA8BB-EF3E-4988-B816-B66E1C4BA75DQ24186108-7C56903D-21C8-43CA-9FD6-5A1D8CA6AC2CQ24200454-C34634F2-97A7-4441-B02A-99E0F226207FQ24236654-E5DFF8AB-9E1B-40F5-9FDE-3A640B31E18FQ24241128-B9DC8910-13F5-4B09-A3ED-F2D008F1481EQ26860032-6FEFBA63-C137-4E10-BABA-FE5D1EFCC7C1Q30394897-3F1D039F-F190-4F06-BC53-1647ECD9354FQ30413154-5C0D1FB4-A953-4E69-8C7C-0911940C6F8DQ33570619-C470ECCB-8E34-47EF-B4FC-EDDC8D9F689FQ33826384-39B12334-D8B3-4EAD-B32F-659D7141B58FQ33859412-8AFD660F-BBE4-48E9-A3AE-0EF59FBA4267Q35040303-5DDA2A8E-7115-4D45-A21D-5EE5CACDDBFFQ35687079-9F746CD3-2DB2-49CE-AD4E-5698DDD53B11Q39627833-A8F36BCA-F124-46D8-A2F2-3753D8E42CFFQ40379215-9C30BA0A-DC5A-4B92-A586-9BACF40C8844Q42273750-9D92C58A-6FE4-4C70-8205-4B37905B1C45Q54433695-D0E59AA2-4439-4EAE-BB09-27169D0BB040
P2860
Oseltamivir for treatment and prophylaxis of influenza infection
description
im Mai 2009 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована у квітні 2009
@uk
name
Oseltamivir for treatment and prophylaxis of influenza infection
@en
Oseltamivir for treatment and prophylaxis of influenza infection
@nl
type
label
Oseltamivir for treatment and prophylaxis of influenza infection
@en
Oseltamivir for treatment and prophylaxis of influenza infection
@nl
prefLabel
Oseltamivir for treatment and prophylaxis of influenza infection
@en
Oseltamivir for treatment and prophylaxis of influenza infection
@nl
P2860
P1476
Oseltamivir for treatment and prophylaxis of influenza infection
@en
P2093
Patricia Schirmer
P2860
P356
10.1517/14740330902840519
P407
P577
2009-04-09T00:00:00Z
2009-05-01T00:00:00Z